Table 2. Clinical Stages: CTCL/Mycosis Fungoides IA: <10% body surface area involved, flat or slightly raised skin lesions; no skin tumors, no lymph nodes or visceral involvement ...

Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma. It is characterized by malignant T-cell lymphocytes in the skin. It presents as patch, plaque, or tumor stage and is ...

A 72-year-old man with a 3-year history of hypersensitivity skin reaction managed with topical steroids and ultraviolet B (UVB) radiation develops skin tumors chiefly involving his face. After a ...

Greater BSA involvement in patients with early-stage mycosis fungoides is associated with worse overall survival, especially in patients with plaques.

Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides. ... fungoides patients have few efficacious and safe therapeutic options at advanced stages.

In patients with mycosis fungoides (MF), ... Stage IV MF was independently associated with worse overall survival (HR, 23.36; 95% CI, 3.61-150.93; ...

Asian patients are often diagnosed with mycosis fungoides at a younger age compared with other races and therefore may have higher overall survival rates, according to a study.“Mycosis fungoides ...

Mycosis fungoides (MF), the most common subtype of non-Hodgkin’s lymphoma, affects the skin, blood, lymph nodes and viscera and often requires long-term therapy, the researchers added.

A 72-year-old man with a 3-year history of hypersensitivity skin reaction managed with topical steroids and ultraviolet B (UVB) radiation develops skin tumors chiefly involving his face. After a ...